We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
W.R. Berkley
WRB
$28.1B
| $208K | 0.01% |
+12,849
| New | +$210K |
|
1527
Republic Services
RSG
$67.4B
| $207K | 0.01% |
+4,714
| New | +$206K |
|
1528
Semtech
SMTC
$9.65B
| $207K | 0.01% |
10,919
-56,730
| -84% | -$1.04M |
|
1529
Stantec
STN
$8.17B
| $207K | 0.01% |
+8,332
| New | +$208K |
|
1530
ACI Worldwide
ACIW
$6.12B
| $206K | 0.01% |
+9,629
| New | +$222K |
|
1531
Consolidated Edison
ED
$41.4B
| $206K | 0.01% |
+3,197
| New | +$205K |
|
1532
RB Global
RBA
$21.5B
| $206K | 0.01% |
8,555
-358
| -4% | -$9.19K |
|
|
WPG
1533
DELISTED
Washington Prime Group Inc.
WPG
| $206K | 0.01% |
2,154
+844
| +64% | +$85.6K |
|
1534
Eldorado Gold
EGO
$8.33B
| $205K | 0.01% |
+13,833
| New | +$233K |
|
1535
CALL
Johnson & Johnson
JNJ
$640B
| $205K | 0.01% |
+2,000
| New | +$201K |
|
|
POT
1536
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
| $205K | 0.01% |
12,000
| – | – |
|
|
POT
1537
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $205K | 0.01% |
12,000
-1,000
| -8% | -$19.9K |
|
|
SFG
1538
DELISTED
STANCORP FINL GRP
SFG
| $205K | 0.01% |
1,800
-7,088
| -80% | -$809K |
|
1539
Columbia Sportswear
COLM
$3.25B
| $203K | 0.01% |
+4,167
| New | +$213K |
|
|
IRBT
1540
DELISTED
iRobot
IRBT
| $203K | 0.01% |
+5,724
| New | +$185K |
|
1541
Regency Centers
REG
$14.9B
| $202K | 0.01% |
+2,966
| New | +$197K |
|
|
ISLE
1542
DELISTED
Isle of Capri Casinos Inc
ISLE
| $202K | 0.01% |
+14,492
| New | +$252K |
|
1543
Darling Ingredients
DAR
$9.32B
| $198K | 0.01% |
18,827
-19,972
| -51% | -$208K |
|
1544
CNX Resources
CNX
$4.91B
| $195K | 0.01% |
29,520
-118,843
| -80% | -$840K |
|
|
OSG
1545
Octave Specialty Group
OSG
$257M
| $194K | 0.01% |
13,819
-15,530
| -53% | -$239K |
|
1546
Kosmos Energy
KOS
$1.47B
| $194K | 0.01% |
+37,361
| New | +$248K |
|
|
ABB
1547
DELISTED
ABB Ltd
ABB
| $194K | 0.01% |
+10,954
| New | +$202K |
|
|
DYN
1548
DELISTED
Dynegy, Inc.
DYN
| $193K | 0.01% |
14,368
-2,910
| -17% | -$49.9K |
|
|
PKY
1549
DELISTED
Parkway, Inc.
PKY
| $191K | 0.01% |
+12,219
| New | +$200K |
|
1550
Celestica
CLS
$37.8B
| $189K | 0.01% |
+17,152
| New | +$198K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.